Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (119)

2007

  1. Course of vascular access and relationship with treatment of anemia

    Clinical Journal of the American Society of Nephrology, Vol. 2, Núm. 6, pp. 1163-1169

2005

  1. Psychosocial factors and health-related quality of life in hemodialysis patients

    Quality of Life Research, Vol. 14, Núm. 1, pp. 179-190

2004

  1. Diferencias en la calidad de vida relacionada con la salud entre hombres y mujeres en tratamiento en hemodiálisis

    Nefrologia, Vol. 24, Núm. 2, pp. 167-178

  2. The influence of extracellular fluid volume on serum proteins in peritoneal dialysis patients

    Minerva Urologica e Nefrologica, Vol. 56, Núm. 4, pp. 367-369

2003

  1. PRE-dialysis survey on anaemia management

    Nephrology Dialysis Transplantation, Vol. 18, Núm. 1, pp. 89-100

  2. Predialysis survey on anemia management: Patient referral

    American Journal of Kidney Diseases, Vol. 41, Núm. 1, pp. 49-61

  3. Psychosocial factors and quality of life in young hemodialysis patients with low comorbidity

    Journal of Nephrology, Vol. 16, Núm. 6, pp. 886-894

2001

  1. Acute renal failure after bacteraemia and endocarditis

    Nephrology Dialysis Transplantation, Vol. 16, Núm. 11, pp. 2265-2266

  2. Chronic kidney disease: Why is current management uncoordinated and suboptimal?

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 7, pp. 61-64

  3. Concluding remarks

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 2, pp. 19-20

  4. Diabetes mellitus as cause of terminal renal failure. An epidemic of the 21st Century?

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 3, pp. 83-87

  5. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 78-81

  6. Haemodialysis dose, extracellular volume control and arterial hypertension

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 98-101

  7. Introduction

    Nephrology Dialysis Transplantation

  8. Patterns of the abstracts submitted and accepted at the Congresses of ERA-EDTA Madrid (1999) and ERA-EDTA and EKRA nice (2000)

    Nephrology Dialysis Transplantation, Vol. 16, Núm. 6, pp. 1117-1119

  9. Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 18, Núm. 4, pp. 175-180

  10. Prevalence of hypertension in renal disease

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 70-73

  11. Quality of life in end-stage renal disease patients

    American Journal of Kidney Diseases, Vol. 38, Núm. 3, pp. 443-464

  12. Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis

    Nephrology Dialysis Transplantation, Vol. 16, Núm. 11, pp. 2188-2193

2000

  1. (L)-Carnitine in dialysis, more than a commercial affair (multiple letters) [3]

    Nephrology Dialysis Transplantation